biotech · Fibrostenotic Crohn’s disease · liver cirrhosis · AGMB
Agomab Therapeutics NV
Agomab Therapeutics NV trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Tel Aviv, USA HQ
2011 Founded
20 Employees
Public company Type
AGMB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tel Aviv, USA
- Founded
- 2011
- Employees
- 20
- Programs
- 6
- Drugs
- 2
- Patents
- 4
Agomab Therapeutics NV clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Agomab Therapeutics NV programs — each row shows trial ID, program name, phase, status, and indication.
Agomab Therapeutics NV trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Agomab Therapeutics NV.